// App-Quantinova.ai

Mo1217 : Effects of Continued Vedolizumab Therapy for Crohn's Disease in Week 6 Induction Therapy Nonresponders

Researchers

Presenter

  • Brian G. Feagan

Principal Investigators

  • Walter Reinisch

  • Michael D. Smyth

  • Jing Xu

  • Asit Parikh

  • Irving Fox

Medical Centers

  • McMaster University, Hamilton, ON, Canada

  • Medical University of Vienna, Vienna, Austria

  • University of California, San Diego, La Jolla, CA

Locations

  • United States

  • Canada

  • Austria

Companies

  • Robarts Clinical Tri

  • Takeda Pharmaceutica

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • open label

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved